Current
7.1×
5-Year Average
8.3×
All-Time High
14.1×
All-Time Low
0.7×
P/S Ratio daily chart for West Pharmaceutical Services (WST)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/S Ratio for West Pharmaceutical Services (WST) from 2001 to 2025
| 2025 | $19.89B | $3.07B | 6.5× | -1.8× | |
| 2024 | $23.91B | $2.89B | 8.3× | -0.6× | |
| 2023 | $26.09B | $2.95B | 8.8× | +2.8× | |
| 2022 | $17.51B | $2.89B | 6.1× | -6.3× | |
| 2021 | $34.94B | $2.83B | 12.3× | +2.6× | |
| 2020 | $20.96B | $2.15B | 9.8× | +3.7× | |
| 2019 | $11.14B | $1.84B | 6.0× | +1.8× | |
| 2018 | $7.24B | $1.72B | 4.2× | -0.4× | |
| 2017 | $7.32B | $1.60B | 4.6× | +0.5× | |
| 2016 | $6.21B | $1.51B | 4.1× | +1.0× | |
| 2015 | $4.35B | $1.40B | 3.1× | +0.4× | |
| 2014 | $3.80B | $1.42B | 2.7× | +0.2× | |
| 2013 | $3.44B | $1.37B | 2.5× | +1.0× | |
| 2012 | $1.87B | $1.27B | 1.5× | +0.4× | |
| 2011 | $1.29B | $1.19B | 1.1× | -0.2× | |
| 2010 | $1.38B | $1.10B | 1.2× | +0.0× | |
| 2009 | $1.30B | $1.06B | 1.2× | +0.1× | |
| 2008 | $1.24B | $1.05B | 1.2× | -0.1× | |
| 2007 | $1.31B | $1.02B | 1.3× | -0.6× | |
| 2006 | $1.68B | $913.30M | 1.8× | +0.7× | |
| 2005 | $795.12M | $699.80M | 1.1× | -0.3× | |
| 2004 | $767.35M | $541.60M | 1.4× | +0.4× | |
| 2003 | $498.78M | $490.70M | 1.0× | +0.2× | |
| 2002 | $353.31M | $419.70M | 0.8× | -0.1× | |
| 2001 | $382.14M | $396.90M | 1.0× | — |
- 20256.5×
- 20248.3×
- 20238.8×
- 20226.1×
- 202112.3×
- 20209.8×
- 20196.0×
- 20184.2×
- 20174.6×
- 20164.1×
- 20153.1×
- 20142.7×
- 20132.5×
- 20121.5×
- 20111.1×
- 20101.2×
- 20091.2×
- 20081.2×
- 20071.3×
- 20061.8×
- 20051.1×
- 20041.4×
- 20031.0×
- 20020.8×
- 20011.0×
About P/S Ratio at West Pharmaceutical Services (WST)
West Pharmaceutical Services (WST) P/S ratio is 7.1× as of June 5, 2026. The 5-year average is 8.3×. The sector median currently stands at 3.5×. The current ratio is at the 33th percentile of its own 10-year history.
West Pharmaceutical Services (WST) historical P/S ratio has ranged from a low of 0.7× (2003) to a high of 14.1× (2021) in the available daily series.
The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.
West Pharmaceutical Services P/S Ratio by Year
West Pharmaceutical Services P/S Ratio 2025: 6.5×
West Pharmaceutical Services (WST) P/S ratio in 2025 was 6.5×, contracted from 8.3× the prior year.
West Pharmaceutical Services P/S Ratio 2024: 8.3×
West Pharmaceutical Services (WST) P/S ratio in 2024 was 8.3×, contracted from 8.8× the prior year.
West Pharmaceutical Services P/S Ratio 2023: 8.8×
West Pharmaceutical Services (WST) P/S ratio in 2023 was 8.8×, expanded from 6.1× the prior year.
West Pharmaceutical Services P/S Ratio 2022: 6.1×
West Pharmaceutical Services (WST) P/S ratio in 2022 was 6.1×, contracted from 12.3× the prior year.
West Pharmaceutical Services P/S Ratio 2021: 12.3×
West Pharmaceutical Services (WST) P/S ratio in 2021 was 12.3×.
Sector peers by P/S Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/S Ratio — table
Healthcare peers of West Pharmaceutical Services (WST), ranked by P/S ratio.
| 2.1× | |
| 2.1× | |
| 2.1× | |
| 1.9× | |
| 1.9× | |
| 1.7× | |
| 1.6× | |
| 1.6× | |
| 1.4× | |
| 1.4× | |
| 1.1× | |
| 0.8× | |
| 0.7× | |
| 0.6× | |
| 0.6× | |
| 0.5× | |
| 0.3× | |
| 0.3× | |
| 0.3× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.1× |
- 2.1×
- 1.7×
- 1.4×
- 1.1×
- 0.7×
- 0.3×
- 0.3×
- 0.2×
- 0.2×
- 0.2×
- 0.1×
Frequently asked questions
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric